NASA's Chemical Transfer Propulsion Program for Pathfinder

Pathfinder is a research and technology project, with specific deliverables, initiated by the National Aeronautics and Space Administration (NASA) which will strengthen the technology base of the United States civil space program in preparation for future space exploration missions. Pathfinder begins in Fiscal Year 1989, and is to advance a collection of critical technologies for these missions and ensure technology readiness for future national decisions regarding exploration of the solar system. The four major thrusts of Pathfinder are: surface exploration, in-space operations, humans-in-space, and space transfer. The space transfer thrust will provide the critical technologies needed for transportation to, and return from, the Moon, Mars, and other planets in the solar system, as well as for reliable and cost-effective Earth-orbit operations. A key element of this thrust is the Chemical Transfer Propulsion program which will provide the propulsion technology for high performance, liquid oxygen/liquid hydrogen expander cycle engines which may be operated and maintained in space. Described here are the program overview including the goals and objectives, management, technical plan, and technology transfer for the Chemical Transfer Propulsion element of Pathfinder

The Pathfinder Chemical Transfer Propulsion Program

Pathfinder is a research and technology initiative by the National Aeronautics and Space Administration (NASA) intended to strengthen the technology base of the United States civil space program in preparation for future space exploration missions. Pathfinder begins in FY-89. One of the four major thrusts is the Chemical Transfer Propulsion program which will provide the propulsion technology for high performance, liquid oxygen/liquid hydrogen expander cycle engines which are expected to be operated and maintained in space. These advanced engines will enhance or enable a variety of future space exploration missions. The goals and objectives, management, technical plan, and technology transfer for the Chemical Transfer Propulsion element of Pathfinder are described

The Pathfinder Chemical Transfer Propulsion program

Pathfinder is a research and technology initiative by the National Aeronautics and Space Administration (NASA) intended to strengthen the technology base of the United States civil space program in preparation for future space exploration missions. Pathfinder begins in FY-89. One of the four major thrusts of Pathfinder is Space Transfer technology. A key element of this thrust is the Chemical Transfer Propulsion program which will provide the propulsion technology for high performance, liquid oxygen/liquid hydrogen expander cycle engines which are expected to be operated and maintained in space. These advanced engines will enhance or enable a variety of future space exploration missions. This paper describes the goals and objectives, management, technical plan, and technology transfer for the Chemical Transfer Propulsion element of Pathfinder

The effect of eddy distribution on momentum and heat transfer near the wall in turbulent pipe flow

A study was conducted to determine the effect of eddy distribution on momentum and heat transfer near the wall in turbulent pipe flow. The buffer zone was of particular interest in that it is perhaps the most complicated and least understood region in the turbulent flow field. Six eddy diffusivity relationships are directly compared on their ability to predict mean velocity and temperature distributions in turbulent air flow through a cylindrical, smooth-walled pipe with uniform heat transfer. Turbulent flow theory and the development of the eddy diffusivity relationships are briefly reviewed. Velocity and temperature distributions derived from the eddy diffusivity relationships are compared to experimental data for fully-developed pipe flow in turbulent air at a Prandtl number of 0.73 and Reynolds numbers ranging from 8100 to 25 000

Architectures for wireless sensor networks

The vision of ubiquitous computing requires the development of devices and technologies that can be pervasive without being intrusive. The basic component of such a smart environment will be a small node with sensing and wireless communications capabilities, able to organize itself flexibly into a network for data collection and delivery. Building such a sensor network presents many significant challenges, especially at the architectural, protocol, and operating system level. Although sensor nodes might be equipped with a power supply or energy scavenging means and an embedded processor that makes them autonomous and self-aware, their functionality and capabilities will be very limited. Therefore, collaboration between nodes is essential to deliver smart services in a ubiquitous setting. New algorithms for networking and distributed collaboration need to be developed. These algorithms will be the key for building self-organizing and collaborative sensor networks that show emergent behavior and can operate in a challenging environment where nodes move, fail, and energy is a scarce resource. The question that rises is how to organize the internal software and hardware components in a manner thatwill allowthem towork properly and be able to adapt dynamically to new environments, requirements, and applications. At the same time the solution should be general enough to be suited for as many applications as possible. Architecture definition also includes, at the higher level, a global view of the whole network. The topology, placement of base stations, beacons, etc. is also of interest. In this chapter, we will present and analyze some of the characteristics of the architectures for wireless sensor networks. Then, we will propose a new dataflow-based architecture that allows, as a new feature, the dynamic reconfiguration of the sensor nodes software at runtime

Multi-agent system for on-demand production integrating production and quality control

Multi-agent systems is being pointed as particularly suited to design and engineer a new class of control systems to operate at the factory plants addressing the current requirements of modularity, flexibility and re-configurability. This paper introduces the main principles of a multi-agent system approach to support the integration of production and quality control processes in washing machines production lines that is being developed under the EU FP7 GRACE project

Place-exchange mechanism of Pt (111) oxidation/reduction as observed by synchrotron X-ray scattering

Structural changes in the Pt(111) single crystal surface associated with incipient electrochemical oxidation/reduction were studied by {ital in}{ital situ} synchrotron x-ray reflectivity. It was shown that lifting of Pt atoms of the surface layer occurs, substantiating the long-standing hypothesis of a place-exchange mechanism for solution/metal interface oxidation. It was also shown that, for a charge transfer of {approx_lt}1.7 e{sup -}/Pt atom, the initially flat surface structure could be recovered by electrochemical reduction. In constrast, the surface was irreversibly roughened for amounts of charge transfer exceeding {approx}1.7 e{sup -}/Pt, but the roughening involved only the atoms in the top layer of the original flat surface. A detailed mechanism is proposed for the place-exchange mechanism and the subsequent roughening of the electrode surface

The Estimation of GC Repeats in Promoter P1 of IGF-1 Gene and Their Influence on IGF-1 Plasma Levels in Stable Angina Patients

Increased plasma levels of insulin-like growth factor 1 (IGF-1) are observed in advanced arteriosclerosis, but the reasons for these elevated levels remain unknown. One possibility to explain them is variation in the sequences that control IGF-1 gene expression. The goal of this study was to determine the effect of molecular variants of the IGF-1 P1 promoter on IGF-1 serum levels and to determine the impact of IGF-1 levels on the severity of coronary atherosclerosis. Methods: Blood samples were collected from 101 consecutive patients undergoing routine angiography. Genomic DNA was isolated from the nucleated cells of the blood plasma as described (2). Based on the presence of conformational differences in the DNA strand and on the absence of single nucleotide polymorphisms, the DNA from 38 patients was further analyzed by the “allelic ladder” method to determine the number of repeated GC dinucleotides in the P1 promoter of the IGF-1 gene. In addition, we analyzed serum growth hormone levels in order to examine the effect on systemic IGF-1 synthesis. Results: Conformational differences in the P1 promoter of the IGF-1 gene were observed in 38 out of the 101 patients. Several genotypes, depending on the number of GC repeats, were observed (11/19,17/19,18/19,18/21,19/19,19/20,19/21). Interestingly, a family history of coronary artery disease was seen less often among individuals heterozygous for the GC repeats. A lower IGF-1 levels were seen in non-variant carriers (homozygous genotypes for 19 or 21 repeats of GC, or heterozygous genotype 19/21) when compared to the variant group (other heterozygous genotypes then 19/21) (181.6 ± 47.9 ng/mL vs. 227.7 ± 73.7, p = 0.026). A correlation between IGF-1, IGF-binding protein number 3, and growth hormone levels (p = ns) was not observed, and there were no significant differences in the growth hormone levels in the studied group of patients (p = ns)

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.

Improved antigenicity against HIV-1 envelope (Env) protein is needed to elicit vaccine-induced protective immunity in humans. Here we describe the first tests in non-human primates (NHPs) of Env gp140 protein fused to a humanized anti-LOX-1 recombinant antibody for delivering Env directly to LOX-1-bearing antigen presenting cells, especially dendritic cells (DC). LOX-1, or 1ectin-like oxidized low-density lipoprotein (LDL) receptor-1, is expressed on various antigen presenting cells and endothelial cells, and is involved in promoting humoral immune responses. The anti-LOX-1 Env gp140 fusion protein was tested for priming immune responses and boosting responses in animals primed with replication competent NYVAC-KC Env gp140 vaccinia virus. Anti-LOX-1 Env gp140 vaccination elicited robust cellular and humoral responses when used for either priming or boosting immunity. Co-administration with Poly ICLC, a TLR3 agonist, was superior to GLA, a TLR4 agonist. Both CD4+ and CD8+ Env-specific T cell responses were elicited by anti-LOX-1 Env gp140, but in particular the CD4+ T cells were multifunctional and directed to multiple epitopes. Serum IgG and IgA antibody responses induced by anti-LOX-1 Env gp140 against various gp140 domains were cross-reactive across HIV-1 clades; however, the sera neutralized only HIV-1 bearing sequences most similar to the clade C 96ZM651 Env gp140 carried by the anti-LOX-1 vehicle. These data, as well as the safety of this protein vaccine, justify further exploration of this DC-targeting vaccine approach for protective immunity against HIV-1

Signaling via interleukin-4, receptor alpha chain is required for successful vaccination against schistosomiasis in BALB/c mice

Radiation-attenuated (RA) schistosome larvae are potent stimulators of innate immune responses at the skin site of exposure (pinna) that are likely to be important factors in the development of Th1-mediated protective immunity. In addition to causing an influx of neutrophils, macrophages, and dendritic cells (DCs) into the dermis, RA larvae induced a cascade of chemokine and cytokine secretion following in vitro culture of pinna biopsy samples. While macrophage inflammatory protein 1 and interleukin-1 (IL-1) were produced transiently within the first few days, the Th1-promoting cytokines IL-12 and IL-18 were secreted at high levels until at least day 14. Assay of C3H/HeJ mice confirmed that IL-12 secretion was not due to lipopolysaccharide contaminants binding Toll-like receptor 4. Significantly, IL-12 p40 secretion was sustained in pinnae from vaccinated mice but not in those from nonprotected infected mice. In contrast, IL-10 was produced from both vaccinated and infected mice. This cytokine regulates IL-12-associated dermal inflammation, since in vaccinated IL-10/ mice, pinna thickness was greatly increased concurrent with elevated levels of IL-12 p40. A significant number of IL-12 p40 cells were detected as emigrants from in vitro-cultured pinnae, and most were within a population of rare large granular cells that were Ia, consistent with their being antigen-presenting cells. Labeling of IL-12 cells for CD11c, CD205, CD8, CD11b, and F4/80 indicated that the majority were myeloid DCs, although a proportion were CD11c F4/80, suggesting that macrophages were an additional source of IL-12 in the skin